Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia
Denosumab is a human monoclonal antibody that binds to RANKL (receptor activator of nuclear factor-kappa B ligand). It has mainly been used in the treatment of osteoporosis for a variety of causes especially in situations refractory to bisphosphonates or when kidney function is impaired. It is also...
Main Authors: | Afdhal Afiq Abd Jalil, Sharifah Faradila Wan Muhamad Hatta, Aimi Fadilah Mohamad, Mohammed Fauzi Abdul Rani |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/5544848 |
Similar Items
-
Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia
by: Abd Jalil, AA, et al.
Published: (2021) -
Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia
by: Abd Jalil, A.A, et al.
Published: (2021) -
Tuberculous Pleural Effusion
by: Shira A. Schlesinger, et al.
Published: (2012-09-01) -
Tuberculose pleural Tuberculous pleural effusions
by: Márcia Seiscento, et al.
Published: (2006-08-01) -
Tuberculous Pleural Effusion in the Elderly
by: Yi-Chun Lai, et al.
Published: (2012-09-01)